Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children

Background: The World Health Organization recommends use of a single yellow fever (YF) vaccine dose for life and fractional doses in outbreaks when there are limited vaccine stocks. In endemic regions, this vaccine is given as part of routine infant immunization programs around 9 months of age. Ther...

Full description

Bibliographic Details
Main Authors: Olubukola T. Idoko, Nuredin Mohammed, Patrick Ansah, Abraham Hodgson, Milagritos D. Tapia, Samba O. Sow, Paanchali R. Chowdhury, Matthias Niedrig, Elmar Saathoff, Beate Kampmann
Format: Article
Language:English
Published: Taylor & Francis Group 2019-08-01
Series:Expert Review of Vaccines
Subjects:
Online Access:http://dx.doi.org/10.1080/14760584.2019.1640118
_version_ 1827813205807726592
author Olubukola T. Idoko
Nuredin Mohammed
Patrick Ansah
Abraham Hodgson
Milagritos D. Tapia
Samba O. Sow
Paanchali R. Chowdhury
Matthias Niedrig
Elmar Saathoff
Beate Kampmann
author_facet Olubukola T. Idoko
Nuredin Mohammed
Patrick Ansah
Abraham Hodgson
Milagritos D. Tapia
Samba O. Sow
Paanchali R. Chowdhury
Matthias Niedrig
Elmar Saathoff
Beate Kampmann
author_sort Olubukola T. Idoko
collection DOAJ
description Background: The World Health Organization recommends use of a single yellow fever (YF) vaccine dose for life and fractional doses in outbreaks when there are limited vaccine stocks. In endemic regions, this vaccine is given as part of routine infant immunization programs around 9 months of age. There is a need to better understand immune responses when vaccinating infants particularly in contexts where the child may be malnourished. Methods: Data from 393 Malian and Ghanaian infants who concomitantly received measles and YF vaccines at 9 to 11 months of age were retrospectively analyzed. Response to YF vaccine was examined for association with nutritional status at time of vaccination, sex, age, pre-vaccination titers and season of vaccination. Results: Neutralizing antibodies following vaccination were unaffected by season of vaccination, sex, pre-vaccination titers or nutritional status, though there was a trend to higher titers in males and children with higher height for age z-scores. Seroconversion rates differed significantly between countries (63.5 in Ghana vs. 91.0% in Mali). Conclusion: Longitudinal, prospective studies are needed to optimize the use of YF vaccine in infants in endemic settings. There may be a need for booster vaccinations and to compare various vaccine preparations to optimize the use of available vaccines.
first_indexed 2024-03-11T23:28:32Z
format Article
id doaj.art-127f5903557c4a9ebc4340dd8b6d5b3c
institution Directory Open Access Journal
issn 1476-0584
1744-8395
language English
last_indexed 2024-03-11T23:28:32Z
publishDate 2019-08-01
publisher Taylor & Francis Group
record_format Article
series Expert Review of Vaccines
spelling doaj.art-127f5903557c4a9ebc4340dd8b6d5b3c2023-09-20T10:18:04ZengTaylor & Francis GroupExpert Review of Vaccines1476-05841744-83952019-08-0118886787510.1080/14760584.2019.16401181640118Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian childrenOlubukola T. Idoko0Nuredin Mohammed1Patrick Ansah2Abraham Hodgson3Milagritos D. Tapia4Samba O. Sow5Paanchali R. Chowdhury6Matthias Niedrig7Elmar Saathoff8Beate Kampmann9Medical Research Council Unit The Gambia at London School of Hygiene and Tropical MedicineMedical Research Council Unit The Gambia at London School of Hygiene and Tropical MedicineGhana Health ServiceGhana Health ServiceUniversity of MarylandUniversity of MarylandRobert Koch InstituteRobert Koch InstituteUniversity HospitalMedical Research Council Unit The Gambia at London School of Hygiene and Tropical MedicineBackground: The World Health Organization recommends use of a single yellow fever (YF) vaccine dose for life and fractional doses in outbreaks when there are limited vaccine stocks. In endemic regions, this vaccine is given as part of routine infant immunization programs around 9 months of age. There is a need to better understand immune responses when vaccinating infants particularly in contexts where the child may be malnourished. Methods: Data from 393 Malian and Ghanaian infants who concomitantly received measles and YF vaccines at 9 to 11 months of age were retrospectively analyzed. Response to YF vaccine was examined for association with nutritional status at time of vaccination, sex, age, pre-vaccination titers and season of vaccination. Results: Neutralizing antibodies following vaccination were unaffected by season of vaccination, sex, pre-vaccination titers or nutritional status, though there was a trend to higher titers in males and children with higher height for age z-scores. Seroconversion rates differed significantly between countries (63.5 in Ghana vs. 91.0% in Mali). Conclusion: Longitudinal, prospective studies are needed to optimize the use of YF vaccine in infants in endemic settings. There may be a need for booster vaccinations and to compare various vaccine preparations to optimize the use of available vaccines.http://dx.doi.org/10.1080/14760584.2019.1640118neutralizing antibodyyellow fever (yf)vaccineafricaninfant
spellingShingle Olubukola T. Idoko
Nuredin Mohammed
Patrick Ansah
Abraham Hodgson
Milagritos D. Tapia
Samba O. Sow
Paanchali R. Chowdhury
Matthias Niedrig
Elmar Saathoff
Beate Kampmann
Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
Expert Review of Vaccines
neutralizing antibody
yellow fever (yf)
vaccine
african
infant
title Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
title_full Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
title_fullStr Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
title_full_unstemmed Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
title_short Antibody responses to yellow fever vaccine in 9 to 11-month-old Malian and Ghanaian children
title_sort antibody responses to yellow fever vaccine in 9 to 11 month old malian and ghanaian children
topic neutralizing antibody
yellow fever (yf)
vaccine
african
infant
url http://dx.doi.org/10.1080/14760584.2019.1640118
work_keys_str_mv AT olubukolatidoko antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT nuredinmohammed antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT patrickansah antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT abrahamhodgson antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT milagritosdtapia antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT sambaosow antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT paanchalirchowdhury antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT matthiasniedrig antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT elmarsaathoff antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren
AT beatekampmann antibodyresponsestoyellowfevervaccinein9to11montholdmalianandghanaianchildren